Lista de obras - Fabio Pastorino - Dominio Público Uruguay

A novel liposomal Clodronate depletes tumor-associated macrophages in primary and metastatic melanoma: Anti-angiogenic and anti-tumor effects.

artículo científico publicado en 2015

ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasis.

artículo científico publicado en 2014

Angiogenesis in neuroblastoma.

artículo científico publicado en 2004

Anti-Tumor Effects of Bak-Proteoliposomes against Glioblastoma.

artículo científico publicado en 2015

Chromogranin A binds to αvβ6-integrin and promotes wound healing in mice.

artículo científico publicado en 2012

Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma

artículo científico publicado en 2010

Combined therapeutic effects of vinblastine and rapamycin on human neuroblastoma growth, apoptosis, and angiogenesis

artículo científico publicado en 2007

Critical role of flanking residues in NGR-to-isoDGR transition and CD13/integrin receptor switching

artículo científico publicado en 2010

Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects.

artículo científico

Development of Fab' fragments of anti-GD(2) immunoliposomes entrapping doxorubicin for experimental therapy of human neuroblastoma.

artículo científico publicado en 2003

Discovery of a novel glucose metabolism in cancer: The role of endoplasmic reticulum beyond glycolysis and pentose phosphate shunt

artículo científico publicado en 2016

Doxorubicin effect on myocardial metabolism as a pre-requisite for subsequent development of cardiac toxicity: a translational (18)F-FDG PET/CT observation.

artículo científico publicado en 2017

Doxorubicin-loaded Fab' fragments of anti-disialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude mice

artículo científico publicado en 2003

Drug delivery systems: application of liposomal anti-tumor agents to neuroectodermal cancer treatment

artículo científico publicado en 2008

Enhanced anti-tumor activity of a new curcumin-related compound against melanoma and neuroblastoma cells

artículo científico publicado en 2010

Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin

artículo científico publicado en 2008

Enhancement of Tumor Homing by Chemotherapy-Loaded Nanoparticles

scientific article published on 07 October 2018

Extracts from Cell Suspension Cultures of Strawberry (Fragaria x ananassa Duch): Cytotoxic Effects on Human Cancer Cells

artículo científico publicado en 2019

Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomas.

artículo científico publicado en 2011

GD2-mediated melanoma cell targeting and cytotoxicity of liposome-entrapped fenretinide

Glycine N-methylation in NGR-Tagged Nanocarriers Prevents Isoaspartate formation and Integrin Binding without Impairing CD13 Recognition and Tumor Homing

artículo científico publicado en 2017

Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs.

artículo científico publicado en 2004

Immunoliposomal fenretinide: a novel antitumoral drug for human neuroblastoma.

artículo científico publicado en 2003

Immunotherapy in the Treatment of Human Solid Tumors: Basic and Translational Aspects.

artículo científico publicado en 2016

In vitro and in vivo antitumor activity of liposomal Fenretinide targeted to human neuroblastoma.

artículo científico publicado en 2003

In vivo angiogenic activity of neuroblastoma correlates withMYCN oncogene overexpression

scientific article published on 01 December 2002

Ligand-targeted liposomal therapies of neuroblastoma.

artículo científico publicado en 2007

Liposome-mediated therapy of neuroblastoma

artículo científico publicado en 2009

Microfragmented human fat tissue is a natural scaffold for drug delivery: Potential application in cancer chemotherapy

scientific article published on 16 March 2019

Molecular galactose-galectin association in neuroblastoma cells: An unconventional tool for qualitative/quantitative screening

artículo científico publicado en 2017

Nanocarrier-mediated targeting of tumor and tumor vascular cells improves uptake and penetration of drugs into neuroblastoma.

artículo científico

Neuroblastoma targeting by c-myb-selective antisense oligonucleotides entrapped in anti-GD2 immunoliposome: immune cell-mediated anti-tumor activities.

artículo científico publicado en 2005

Neuroblastoma tumorigenesis is regulated through the Nm23-H1/h-Prune C-terminal interaction

artículo científico publicado en 2013

Neuroblastoma-targeted nanocarriers improve drug delivery and penetration, delay tumor growth and abrogate metastatic diffusion

artículo científico publicado en 2015

New therapeutic strategies in neuroblastoma: combined targeting of a novel tyrosine kinase inhibitor and liposomal siRNAs against ALK.

artículo científico publicado en 2015

Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings.

artículo científico publicado en 2013

Overcoming Biological Barriers in Neuroblastoma Therapy: The Vascular Targeting Approach with Liposomal Drug Nanocarriers

artículo científico publicado en 2019

PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance

artículo científico publicado en 2015

Potent and sustained inhibition of HIF-1α and downstream genes by a polyethyleneglycol-SN38 conjugate, EZN-2208, results in anti-angiogenic effects

artículo científico publicado en 2011

Preclinical evaluation of the first intravenous small molecule MDM2 antagonist alone and in combination with temozolomide in neuroblastoma

scientific article published on 09 January 2019

Selective therapeutic targeting of the anaplastic lymphoma kinase with liposomal siRNA induces apoptosis and inhibits angiogenesis in neuroblastoma

artículo científico publicado en 2011

Spatiotemporal Regulation of Tumor Angiogenesis by Circulating Chromogranin A Cleavage and Neuropilin-1 Engagement

scientific article published on 22 February 2019

Special Issue "Recent Advances in Precision Nanomedicine for Cancer"

artículo científico publicado en 2020

Spot overlapping in two-dimensional maps: a serious problem ignored for much too long

artículo científico publicado en 2005

Targeted delivery system for antisense oligonucleotides: a novel experimental strategy for neuroblastoma treatment.

artículo científico publicado en 2003

Targeted drug delivery and penetration into solid tumors

artículo científico publicado en 2011

Targeting Macrophages as a Potential Therapeutic Intervention: Impact on Inflammatory Diseases and Cancer

artículo científico publicado en 2018

Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma

artículo científico publicado en 2020

Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy

artículo científico publicado en 2006

The Neuronal Pentraxin-2 Pathway Is an Unrecognized Target in Human Neuroblastoma, Which Also Offers Prognostic Value in Patients.

artículo científico publicado en 2015

The combined therapeutic effects of bortezomib and fenretinide on neuroblastoma cells involve endoplasmic reticulum stress response

artículo científico publicado en 2009

Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma

artículo científico publicado en 2015

Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy

artículo científico publicado en 2003

sTRAIL coupled to liposomes improves its pharmacokinetic profile and overcomes neuroblastoma tumour resistance in combination with Bortezomib

artículo científico publicado en 2014

Lista de obras de Fabio Pastorino

A novel liposomal Clodronate depletes tumor-associated macrophages in primary and metastatic melanoma: Anti-angiogenic and anti-tumor effects.

ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasis.

Angiogenesis in neuroblastoma.

Anti-Tumor Effects of Bak-Proteoliposomes against Glioblastoma.

Chromogranin A binds to αvβ6-integrin and promotes wound healing in mice.

Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma

Combined therapeutic effects of vinblastine and rapamycin on human neuroblastoma growth, apoptosis, and angiogenesis

Critical role of flanking residues in NGR-to-isoDGR transition and CD13/integrin receptor switching

Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects.

Development of Fab' fragments of anti-GD(2) immunoliposomes entrapping doxorubicin for experimental therapy of human neuroblastoma.

Discovery of a novel glucose metabolism in cancer: The role of endoplasmic reticulum beyond glycolysis and pentose phosphate shunt

Doxorubicin effect on myocardial metabolism as a pre-requisite for subsequent development of cardiac toxicity: a translational (18)F-FDG PET/CT observation.

Doxorubicin-loaded Fab' fragments of anti-disialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude mice

Drug delivery systems: application of liposomal anti-tumor agents to neuroectodermal cancer treatment

Enhanced anti-tumor activity of a new curcumin-related compound against melanoma and neuroblastoma cells

Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin

Enhancement of Tumor Homing by Chemotherapy-Loaded Nanoparticles

Extracts from Cell Suspension Cultures of Strawberry (Fragaria x ananassa Duch): Cytotoxic Effects on Human Cancer Cells

Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomas.

GD2-mediated melanoma cell targeting and cytotoxicity of liposome-entrapped fenretinide

Glycine N-methylation in NGR-Tagged Nanocarriers Prevents Isoaspartate formation and Integrin Binding without Impairing CD13 Recognition and Tumor Homing

Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs.

Immunoliposomal fenretinide: a novel antitumoral drug for human neuroblastoma.

Immunotherapy in the Treatment of Human Solid Tumors: Basic and Translational Aspects.

In vitro and in vivo antitumor activity of liposomal Fenretinide targeted to human neuroblastoma.

In vivo angiogenic activity of neuroblastoma correlates withMYCN oncogene overexpression

Ligand-targeted liposomal therapies of neuroblastoma.

Liposome-mediated therapy of neuroblastoma

Microfragmented human fat tissue is a natural scaffold for drug delivery: Potential application in cancer chemotherapy

Molecular galactose-galectin association in neuroblastoma cells: An unconventional tool for qualitative/quantitative screening

Nanocarrier-mediated targeting of tumor and tumor vascular cells improves uptake and penetration of drugs into neuroblastoma.

Neuroblastoma targeting by c-myb-selective antisense oligonucleotides entrapped in anti-GD2 immunoliposome: immune cell-mediated anti-tumor activities.

Neuroblastoma tumorigenesis is regulated through the Nm23-H1/h-Prune C-terminal interaction

Neuroblastoma-targeted nanocarriers improve drug delivery and penetration, delay tumor growth and abrogate metastatic diffusion

New therapeutic strategies in neuroblastoma: combined targeting of a novel tyrosine kinase inhibitor and liposomal siRNAs against ALK.

Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings.

Overcoming Biological Barriers in Neuroblastoma Therapy: The Vascular Targeting Approach with Liposomal Drug Nanocarriers

PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance

Potent and sustained inhibition of HIF-1α and downstream genes by a polyethyleneglycol-SN38 conjugate, EZN-2208, results in anti-angiogenic effects

Preclinical evaluation of the first intravenous small molecule MDM2 antagonist alone and in combination with temozolomide in neuroblastoma

Selective therapeutic targeting of the anaplastic lymphoma kinase with liposomal siRNA induces apoptosis and inhibits angiogenesis in neuroblastoma

Spatiotemporal Regulation of Tumor Angiogenesis by Circulating Chromogranin A Cleavage and Neuropilin-1 Engagement

Special Issue "Recent Advances in Precision Nanomedicine for Cancer"

Spot overlapping in two-dimensional maps: a serious problem ignored for much too long

Targeted delivery system for antisense oligonucleotides: a novel experimental strategy for neuroblastoma treatment.

Targeted drug delivery and penetration into solid tumors

Targeting Macrophages as a Potential Therapeutic Intervention: Impact on Inflammatory Diseases and Cancer

Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma

Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy

The Neuronal Pentraxin-2 Pathway Is an Unrecognized Target in Human Neuroblastoma, Which Also Offers Prognostic Value in Patients.

The combined therapeutic effects of bortezomib and fenretinide on neuroblastoma cells involve endoplasmic reticulum stress response

Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma

Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy

sTRAIL coupled to liposomes improves its pharmacokinetic profile and overcomes neuroblastoma tumour resistance in combination with Bortezomib